PRODUCT DETAILS

About Adiglipt M 500mg/20mg Tablet

METFORMIN+TENELIGLIPTIN belongs to the group of medications called ‘antidiabetic agents’ used to treat Type 2 diabetes mellitus. This medication improves glycaemic control in diabetic patients in those patients who do not react well to Metformin alone.  Type 2 diabetes mellitus is a chronic or life-long condition in which blood sugar or glucose levels rise more than normal. It occurs when the body does not produce enough insulin (metabolizes glucose), or if produced, it cannot function properly in the body.

Uses of Adiglipt M 500mg/20mg Tablet

Type 2 Diabetes Mellitus

Medicinal Benefits of Adiglipt M 500mg/20mg Tablet

METFORMIN+TENELIGLIPTIN is suggested for the management of type 2 diabetes to be followed with the right diet and exercise. METFORMIN+TENELIGLIPTIN is given in combination in patients whose diabetes is not effectively controlled with Metformin alone.  This medicine makes the body more responsive to insulin and helps the body to a normal state.  Metformin tablets are especially advised to release the drug at a slow rate in the body from time to time.

Directions for Use

METFORMIN+TENELIGLIPTIN is available in the form of tablets. Usually, your doctor may suggest the lowest dose; after that, the doctor will measure the blood sugar levels and adjust the dose. Tablets: Tablets are swallowed as a whole with a glass of water. Do not crush, chew, or break the tablets. Take the dose as prescribed by your doctor at a fixed time every day. The doctor may advise you to take it once a day as it is available in the extended-release form.

Side Effects of Adiglipt M 500mg/20mg Tablet

• Nausea (feeling sick)
• Vomiting (falling sick)
• Diarrhea
• Headache
• Stomach ache
• Respiratory infection
• Weight gain
• Sweating
• Palpitations
• Numbness
• Vision problems

Similar Drugs

For informational purposes only. Consult a doctor before taking any medicines.

In-Depth Precautions and Warning

Drug Warnings

METFORMIN+TENELIGLIPTIN should be used with caution in patients with heart diseases as it increases the risk of heart failure. METFORMIN+TENELIGLIPTIN may cause ‘lactic acidosis’ (buildup of lactic acid in the blood), characterized by abdominal pain, muscle cramps, vomiting, severe fatigue, and difficulty breathing. It is a life-threatening condition that requires immediate medical attention. Inform your doctor if you have any severe liver or kidney problems as their normal functioning is required to eliminate excess lactic acid from the body.  Do not consume excess alcohol as it increases the risk of lactic acidosis.  METFORMIN+TENELIGLIPTIN may lower vitamin B12 levels, so it is recommended to take blood tests regularly to identify any vitamin deficiencies.

Drug Interactions

Drug-Drug Interaction:

METFORMIN+TENELIGLIPTIN may have an interaction with medicines used to treat bacterial infections (rifampicin, tetracycline, Clarithromycin), a medicine used to treat fungal infections (fluconazole), other oral antidiabetics, medicines used to treat gout (probenecid).

Drug-Disease Interaction:

 METFORMIN+TENELIGLIPTIN should be avoided in patients with heart diseases (congestive heart failure and myocardial infarction), vitamin B12 deficiency, and alcoholism, type I diabetes, bladder cancer, oedema (fluid retention), liver disease, premenopausal anovulation, obesity (weight gain), anaemia should avoid intake of METFORMIN+TENELIGLIPTIN.

Safety Advice

ALCOHOL

• Alcohol may increase the risk of side-effects and worsen the condition.

PREGNANCY

• METFORMIN+TENELIGLIPTIN is a category C drug and may cause harmful effects to the unborn baby. So, it is used only when the benefits of this medicine outweigh the risks.

BREAST FEEDING

• METFORMIN+TENELIGLIPTIN should not be used in breastfeeding mothers as it may get secreted in the breast milk and cause unwanted effects in the nursing babies.

DRIVING

• METFORMIN+TENELIGLIPTIN may cause vision problems. So, do not drive or operate heavy machinery if you have any problems with your vision while using METFORMIN+TENELIGLIPTIN.

LIVER

• METFORMIN+TENELIGLIPTIN should be taken with caution in patients with liver diseases. The dose may have to be adjusted by your doctor.

KIDNEY

• METFORMIN+TENELIGLIPTIN should be taken with caution, especially if you have a history of kidney diseases. The dose may have to be adjusted by your doctor.